Jane Street Group LLC Has $2.19 Million Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

Jane Street Group LLC cut its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 25.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 25,918 shares of the company’s stock after selling 8,849 shares during the quarter. Jane Street Group LLC owned approximately 0.17% of U.S. Physical Therapy worth $2,193,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. Canada Pension Plan Investment Board acquired a new position in U.S. Physical Therapy in the 2nd quarter worth about $28,000. Innealta Capital LLC acquired a new stake in shares of U.S. Physical Therapy during the 2nd quarter valued at about $30,000. Quest Partners LLC grew its stake in shares of U.S. Physical Therapy by 2,808.3% in the 2nd quarter. Quest Partners LLC now owns 349 shares of the company’s stock valued at $32,000 after buying an additional 337 shares in the last quarter. Quarry LP increased its holdings in U.S. Physical Therapy by 1,291.9% in the second quarter. Quarry LP now owns 515 shares of the company’s stock worth $48,000 after buying an additional 478 shares during the last quarter. Finally, Ridgewood Investments LLC bought a new position in U.S. Physical Therapy during the second quarter valued at approximately $51,000.

U.S. Physical Therapy Stock Down 1.6 %

U.S. Physical Therapy stock opened at $89.84 on Tuesday. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78. U.S. Physical Therapy, Inc. has a fifty-two week low of $76.18 and a fifty-two week high of $113.63. The firm has a fifty day moving average price of $90.96 and a two-hundred day moving average price of $89.61. The firm has a market cap of $1.36 billion, a price-to-earnings ratio of 95.57, a P/E/G ratio of 4.23 and a beta of 1.46.

U.S. Physical Therapy Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Friday, November 15th were given a dividend of $0.44 per share. The ex-dividend date was Friday, November 15th. This represents a $1.76 annualized dividend and a dividend yield of 1.96%. U.S. Physical Therapy’s dividend payout ratio is presently 187.23%.

Wall Street Analyst Weigh In

Several analysts have commented on the stock. Citizens Jmp raised shares of U.S. Physical Therapy to a “strong-buy” rating in a research report on Monday, December 16th. Barrington Research reaffirmed an “outperform” rating and issued a $108.00 price objective on shares of U.S. Physical Therapy in a research note on Thursday, November 21st. JMP Securities initiated coverage on shares of U.S. Physical Therapy in a research report on Monday, December 16th. They set an “outperform” rating and a $113.00 target price on the stock. Bank of America raised U.S. Physical Therapy from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $100.00 to $115.00 in a research report on Monday, December 16th. Finally, JPMorgan Chase & Co. upped their price target on U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a research note on Tuesday, December 3rd. One analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, U.S. Physical Therapy presently has a consensus rating of “Buy” and a consensus target price of $114.00.

Insider Activity at U.S. Physical Therapy

In other U.S. Physical Therapy news, Director Nancy Ham sold 1,172 shares of the stock in a transaction on Friday, November 8th. The shares were sold at an average price of $96.72, for a total value of $113,355.84. Following the completion of the sale, the director now directly owns 1,112 shares of the company’s stock, valued at $107,552.64. This represents a 51.31 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Carey P. Hendrickson sold 516 shares of the stock in a transaction on Monday, December 9th. The shares were sold at an average price of $96.25, for a total transaction of $49,665.00. Following the completion of the sale, the chief financial officer now directly owns 20,469 shares of the company’s stock, valued at approximately $1,970,141.25. This trade represents a 2.46 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 7,412 shares of company stock worth $706,605 in the last 90 days. 1.70% of the stock is owned by company insiders.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.